Commentary on the real-world effectiveness of vedolizumab in therapy-experienced ulcerative colitis: A response to Azzam et al

关于维多珠单抗在既往接受过治疗的溃疡性结肠炎患者中的真实世界疗效的评论：对 Azzam 等人的回应